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Background:  Previous  research  has  indicated  a  strong  association  of  smoking  with  depression  and  anxiety
disorders,  but  the  direction  of  the  relationship  is  uncertain.  Most  research  has  been  done  in  general
population  samples.  We  investigated  the  effect  of smoking  and  nicotine  dependence  on  the  severity  and
course  of  depressive  and  anxiety  symptoms  in  psychiatric  patients.
Methods:  Data  came  from  the  Netherlands  Study  of  Depression  and  Anxiety  (NESDA)  including partici-
pants  with  a  current  diagnosis  of  depression  and/or  an  anxiety  disorder  (N  =  1725).  The  course  of  smoking
status  and  symptoms  of  depression,  general  anxiety,  social  anxiety,  and  agoraphobia  were  measured  at
baseline  and  after  one  and  two  years.  Age,  gender,  education,  alcohol  use,  physical  activity,  and  negative
life  events  were  treated  as  covariates.
Results:  At  baseline,  the  symptoms  of  depression,  general  anxiety,  and  agoraphobia  were  more  severe
in  nicotine-dependent  smokers  than  in never-smokers,  former  smokers,  and  non-dependent  smokers.
These  differences  remained  after  adjusting  for covariates.  Smaller  differences  were  observed  for  severity
of social  anxiety  which  were  no  longer  signiﬁcant  after  controlling  for covariates.  Over  a  two-year  follow-
up, the  improvement  of depressive  and  anxiety  symptoms  was  slower  in  nicotine-dependent  smokers
than  in  the  other  groups  even  after  controlling  for covariates.  There  were  no  differences  between  the
groups  in  the  course  of  symptoms  of  social  anxiety  and  agoraphobia  over  time.
Conclusions:  In psychiatric  patients,  smoking  is  associated  with  higher  severity  of depressive  and  anxiety
symptoms,  and  with  slower  recovery,  but  only  when  smokers  are  nicotine-dependent.. Introduction
The relationship of smoking and nicotine dependence with
epression (Brown et al., 2000; Goodman and Capitman, 2000;
teuber and Danner, 2006) and anxiety disorders (Isensee et al.,
003; McCabe et al., 2004; Mykletun et al., 2008; Sonntag et al.,
000) has been well-established in epidemiological research.
ross-sectional studies have indicated an elevated level of depres-
ive and anxiety symptoms in smokers than in never- and former
mokers (Benjet et al., 2004; Haukkala et al., 2000; Lam et al.,
004; Lee Ridner et al., 2005; Luk and Tsoh, 2010; Martini et al.,
 Supplementary material can be found by accessing the online version of this
aper. Please see Appendix A.
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2002; Mykletun et al., 2008; Patton et al., 1996; Wiesbeck et al.,
2008; Zvolensky et al., 2003a).  Furthermore, successful quitters
have fewer depressive symptoms and lifetime depression and anx-
iety diagnoses than unsuccessful quitters and current smokers
(McClave et al., 2009). However, smokers meeting criteria for major
depression have a harder time quitting and are more likely to be
heavy smokers (Hebert et al., 2011). The severity of symptoms
is related to the number of cigarettes smoked per day or heavy
smoking (Almeida and Pfaff, 2005; Benjet et al., 2004; Massak and
Graham, 2008) and number of days smoked (Lee Ridner et al.,
2005). Further, nicotine-dependent smokers have more severe
depressive and anxiety symptoms than non-dependent smokers
(Breslau et al., 1991; Brown et al., 2000; Son et al., 1997). Recur-
ring depression is associated with worst smoking-related behaviors
than a single episode or a history of depression. For example,
Open access under the Elsevier OA license.smokers with recurrent episodes of major depression smoked
more cigarettes, were nicotine-dependent more often and reported
fewer quit attempts than never-depressed smokers. Those with a
single episode were indistinguishable from the never-depressed
ol Dep
s
(
d
s
o
i
B
e
i
s
p
w
f
s
n
c
d
a
R
e
c
L
o
a
s
2
t
L
p
i
e
m
(
a
d
e
e
d
s
n
t
o
2
b
M
B
2
2
a
e
e
R
G
e
r
(
a
t
a
i
s
i
tM. Jamal et al. / Drug and Alcoh
mokers on most parameters, including lifetime cessation attempts
Strong et al., 2010). A meta-analysis revealed that a history of major
epression does not seem to predict the success or failure of a
moking cessation attempt (Hitsman et al., 2003).
Cross-sectional studies have also indicated a high prevalence
f current smoking in individuals with lifetime depression, anx-
ety, or comorbid depression and anxiety (Anda et al., 1990;
aker-Morissette et al., 2004; Escobedo et al., 1996; Glassman
t al., 1990; McCabe et al., 2004; Zvolensky et al., 2003b)  than
n the general population. Smoking prevalence is higher among
everely depressed than among mildly and moderately depressed
atients (Tanskanen et al., 1999). These associations of smoking
ith depressive/anxiety disorders remain even after controlling
or potential confounders such as socio-demographic variables,
ubstance use/dependence, increased work hours, social isolation,
euroticism, novelty seeking, childhood conduct problems and
hildhood abuse, adverse life events, parental smoking history,
eviant peers, family instability and anxiety disorders (Almeida
nd Pfaff, 2005; Duncan and Rees, 2005; Fergusson et al., 2003; Lee
idner et al., 2005; Patton et al., 1996; Scott et al., 2009; Wiesbeck
t al., 2008).
The direction of causality of smoking-psychopathology asso-
iation has not yet been fully understood (Dierker et al., 2002).
ongitudinal studies have attempted to explain the mechanisms
f the association by charting the timeline of smoking behavior
nd depression/anxiety disorders. Several studies have demon-
trated that depressive and anxiety disorders (Breslau et al.,
004b; Fergusson et al., 2003; Sihvola et al., 2008) and symp-
oms (McKenzie et al., 2010; Patton et al., 1998; Prinstein and
a Greca, 2009; Repetto et al., 2005), and social fears and social
hobia (Sonntag et al., 2000) increase the likelihood of start-
ng smoking and progression to nicotine dependence (Fergusson
t al., 2003). These results lead to the assumption that smoking
ay  serve as self-medication to ameliorate negative symptoms
Murphy et al., 2003). Other studies have found that smoking is
 vulnerability factor in the development of depression/anxiety
isorders (Breslau et al., 2004a; Duncan and Rees, 2005; John
t al., 2004; Klungsoyr et al., 2006; Pasco et al., 2008; Rodriguez
t al., 2005; Steuber and Danner, 2006). Furthermore, nicotine-
ependent smokers have more severe depressive and anxiety
ymptoms than non-dependent smokers in a 13-year longitudi-
al study (Pedersen and von Soest, 2009). Thus, these data lead
o the assumption that smoking has a predictive role in the onset
r increasing severity of these disorders (Steuber and Danner,
006). Several longitudinal studies have found evidence for a
idirectional smoking-depression/anxiety relationship (Audrain-
cGovern et al., 2009; Breslau et al., 1993; Breslau and Klein, 1999;
rown et al., 1996; Cuijpers et al., 2007; Goodman and Capitman,
000; Isensee et al., 2003; Johnson et al., 2000; Kang and Lee,
010; Munafo et al., 2008; Pedersen and von Soest, 2009; Windle
nd Windle, 2001) in which the two conditions mutually inﬂu-
nce each other. Finally, these co-occuring conditions may  also be
xplained partly by common environmental (McCaffery et al., 2003;
eichborn-Kjennerud et al., 2004) and genetic factors (Kendler and
ardner, 2001; Kendler et al., 1993; Korhonen et al., 2007; Lyons
t al., 2008) [for further details, interested readers may  refer to
eviews on smoking and co-occurring depressive/anxiety disorders
Morrell and Cohen, 2006; Zvolensky et al., 2005)].
In summary, the associations of smoking with depression and
nxiety are well-established. Longitudinal studies suggest that
his association is bidirectional. Moreover, the rates of depression
nd anxiety disorders are higher in current smokers, particularly
n heavy, nicotine-dependent smokers and, comparatively lower
ymptoms have been observed in former smokers. Most of the stud-
es in this area are conducted in non-clinical samples drawn from
he general population or schools, and mainly focus on smokingendence 126 (2012) 138– 146 139
behavior. The effect of nicotine dependence has been given rel-
atively little research attention. Further, the majority of these
studies look at sub-threshold symptoms, and not at diagnoses, of
depression and anxiety disorders.
In the present study, we will examine the severity and course
of depressive and anxiety symptoms over two years in smokers
(non-dependent, nicotine-dependent) and non-smokers (never-
smokers, former smokers) with a current diagnosis of depressive
and/or an anxiety disorder. We  hypothesize that: (i) the symptoms
of depression and anxiety would be more severe in nicotine-
dependent smokers than in non-dependent smokers, who would
have more severe symptoms than former smokers and never-
smokers, and (ii) the rate of improvement of anxiety and depressive
symptoms would be slower in current smokers, particularly in
nicotine-dependent smokers than in never-smokers and former
smokers.
2. Methods
2.1. Participants and data
The data came from an on-going naturalistic cohort study, the Netherlands Study
of  Depression and Anxiety (NESDA), started in September 2004, and investigates
the long-term course and consequences of depression and anxiety disorders. The
baseline NESDA sample includes 2981 participants (age range: 18–65 years; 66.4%
females), consisting of persons with a current diagnosis of depression and/or anx-
iety  disorders (57%), persons with a remitted history of the disorders (21%) and
healthy controls (22%). Exclusion criteria were (i) a primary diagnosis of a psychotic
disorder, addiction disorder, obsessive–compulsive disorder, or bipolar disorder,
and (ii) non-ﬂuency in Dutch. Participants were recruited from the community,
general practice settings and mental health care organizations. The baseline data
were collected using self-report questionnaires, interviews, a medical examination,
a  cognitive computer task, and collection of blood and saliva samples. Data were
obtained on the presence, severity, and chronicity of anxiety and depression, as
well  as the demographic characteristics, psychosocial, psychological, physiologi-
cal determinants, life events, health behaviors including alcohol intake, smoking,
drugs, physical activity and genetic measures of the participants. Ethical approval
for  NESDA was  obtained from the ethical review boards of participating centers, and
all  participants signed informed consent [for full details about NESDA design and
sample, see Penninx et al., 2008].
Depressive and anxiety symptoms were assessed again after one year (response
rate = 82%) and then after two years (response rate = 87.1%). In the present study,
only the participants currently diagnosed (past 6 months) with depression and/or
anxiety disorders at the baseline assessment were selected (N = 1725); healthy con-
trols  (N = 661) and remitted depressed participants (N = 595) were excluded. We
used baseline, 1-year and 2-year data of all the variables included in the analyses:
smoking status, confounding variables, and severity of symptoms of depressive and
anxiety disorders.
Those dropped out from the current analyses (16.4%) were signiﬁcantly younger,
had experienced more negative life events (ps < .05; Cohen’s ds ≤ 0.2), and had
higher symptoms of depression, anxiety (ps < .001; Cohen’s d = 0.3) and agoraphobia
(p < .01; Cohen’s d = 0.2) than those in the study. However, no differences were found
in  alcohol consumption and symptoms of social anxiety (ps > .05). Similarly, the
drop-outs were not different in gender distribution (p > .05) from those in the study.
However, they had signiﬁcantly low education and low physical activity (ps > .05)
than those included in the study.
2.2. Measures
2.2.1. Smoking. Participants were classiﬁed into current smokers (nicotine-
dependent and non-dependent), former smokers, and never-smokers. Former
smokers were those who  had stopped smoking deﬁnitively, and never-smokers
were those who  never smoked during their lifetime. The Fagerstrom test for nico-
tine dependence (FTND) was used to assess nicotine dependence (Heatherton et al.,
1991)  in current smokers only. The reliability and internal consistency of FTND have
been found to be adequate in previous research (Pomerleau et al., 1994). The FTND
assesses daily smoking rate, interval between waking up and the ﬁrst cigarette, fre-
quency of smoking after waking up, difﬁculty refraining from smoking in places
where it is forbidden, and despite medical illness, and also difﬁculty giving up the
ﬁrst cigarette in the morning. The sum score of FTND can range from 0 to 10. Cur-
rent smokers with a score of 4 or higher on the FTND in the present study were
deﬁned as nicotine-dependent smokers (Breslau and Johnson, 2000; Burling and
Burling, 2003; Pedersen and von Soest, 2009). Nicotine-dependent smokers were
daily smokers who  smoked on daily, regular basis. Of the non-dependent smokers,
87%  were daily smokers, smoking between 1 and 30 cigarettes per day, and the
remaining 13% smoked less than 7 cigarettes per week. Smoking status of the par-
ticipants was relatively stable from baseline to wave 3. Never- and former smokers
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t  baseline did not change their smoking status at wave 3. Of the total study sam-
le,  3.2% non-dependent smokers (N = 55) and 1.3% dependent smokers (N = 22) quit
moking at wave 3. This data is included in longitudinal analysis.
.2.2. Psychopathology. The lifetime diagnoses and age at onset of depression and
nxiety disorders were ascertained using the Composite International Diagnostic
nterview (CIDI v2.1). The CIDI is a structured interview designed to assess diagnoses
f  psychiatric disorders according to DSM-IV criteria. The CIDI has high inter-rater
eliability, high test-retest reliability and high validity for depressive and anxiety
isorders (Wittchen et al., 1991).
Depressive symptoms were assessed by the 30-item self-report Inventory of
epressive Symptomatology (IDS; score range: 0–84) which has shown high cor-
elations with observer rated scales (Rush et al., 1996). The 21-item Beck Anxiety
nventory (BAI; score range: 0–62), was used to assess anxiety symptoms (Beck
t  al., 1988) whereas the symptoms of fear were measured with the 15-item Fear
uestionnaire (Marks and Mathews, 1979). In our analyses, we  used two subscales
f  Fear Questionnaire (Marks and Mathews, 1979); (i) FQ items for social anxiety
ymptoms, and (ii) FQ items for agoraphobia symptoms. Both subscales have sufﬁ-
ient internal consistency (Vanzuuren, 1988), and the total score of each subscale
anges from 0 to 40.
.2.3. Potential confounding variables. The Alcohol Use Disorder Identiﬁcation Test
AUDIT; range: 0–40) was used to assess alcohol intake (Babor et al., 1989). The
nternational Physical Activity Questionnaire (IPAQ) was  used to assess self-reported
hysical activity. IPAQ estimates weekly energy expenditure based on daily physical
ctivities (Craig et al., 2003). Negative life events in the past year were assessed with
he  Brugha questionnaire (Brugha et al., 1985). Other covariates under study were
ge, gender and education.
.3. Statistical analyses
Data were screened for accuracy, outlying scores, and the assumptions of uni-
ariate and multivariate analysis. First, we evaluated baseline differences among
icotine-dependent and non-dependent smokers, former smokers, and never-
mokers on the sociodemographic variables and health behaviors using one-way
nalyses of variance (ANOVA) with post hoc tests and chi-square tests for indepen-
ence. Eta squared and Cramer’s V were used as measures of effect size for ANOVA
nd  chi-square, respectively. Then, the cross-sectional associations of smoking with
epressive and anxiety symptoms were examined using a one-way multivariate
NOVA. Four dependent variables were the severity of symptoms of depression,
nxiety, social anxiety and agoraphobia. The independent variable was  smoking
tatus. Multivariate ANOVA was  followed by one-way ANOVAs with post hoc com-
arisons. Next, we performed four hierarchical multiple linear regressions to assess
he  association between smoking status and severity of the disorders while con-
rolling for confounding variables. In each of the regression analyses, we  ﬁtted four
odels. In the ﬁrst model, we  entered age, gender, and education; the second model
able 1
aseline demographic and health behavior characteristics of the participants.
Sociodemographic variables and health
behaviors
Never-smokers
(N = 438)
Current smoke
Non-dependen
(N = 411)
Age of the respondents (mean and SD) 38.4 (13.0) 38.5 (11.9) 
Gender (female) % 70.1 69.1 
Education (%) 
Basic 6.6 5.4 
Intermediate 61 67.4 
High  32.4 28.2 
Alcohol use 2.9 (3.5) 6.3 (5.5) 
Physical activity (%) 
Low 16.9 18.7 
Moderate 43.2 37.7 
High  40.0 43.6 
Stressful events (N) 0.7 (1.0) 0.8 (1.2) 
Current diagnoses (%)
Anxiety 73.5 76.6 
Generalized anxiety 30.4 28 
Social anxiety 36.3 36.7 
Panic
Without agoraphobia 15.5 16.5 
With  agoraphobia 18 28.5 
Agoraphobia 9.8 8.8 
Depression 71.9 66.7 
a Effect size of only signiﬁcant results reported.
* p < .05.
** p < .01.
*** p < .001.pendence 126 (2012) 138– 146
added negative life events and alcohol use to the previous model; similarly, in the
third and fourth models, we  added physical activity and smoking status, respec-
tively, to the previous models. Thus the estimates provided from the ﬁnal model
include all variables.
Finally, to evaluate the change in the severity of the disorders in the four groups
over time linear mixed models (LMMs) were built. The outcome variables were
the severity of the symptoms of depression, anxiety, social anxiety, and agorapho-
bia. Smoking status was modeled both as a ﬁxed factor and a random factor. The
ﬁxed effect of smoking status is the average effect in the entire study population,
expressed by the regression coefﬁcient. The random effect is speciﬁed to investigate
group differences on severity of symptoms as it is assumed that the effect varies ran-
domly within the participants. The covariates gender, education, and negative life
events were modeled as ﬁxed factors, while age, alcohol use and physical activity as
random factors. In NESDA, the data on smoking status are available at baseline and at
follow-up; however, the FTND data are available only at baseline. So while construct-
ing  the data ﬁle for LMM, we  considered the participants as nicotine-dependent
at follow-up if they were dependent at baseline. However, if they quit between
baseline and follow-up period, they were grouped into former smokers. The param-
eters were estimated with maximum likelihood (ML) technique. We speciﬁed the
unstructured repeated and random-effects covariance type because it imposes the
fewest assumptions and comparatively, a better ﬁt of the model. Linear mixed model
approach was  preferred over repeated measures ANOVAs to analyze longitudinal
data  because (i) unlike repeated measures ANOVA, LMMs  can fully accommodate
unbalanced data sets resulting from missing data, common with longitudinal stud-
ies;  (ii) repeated measures ANOVA requires all participants to be assessed at the
same time point, and to have exactly the same number of observations, which is
hardly possible in case of longitudinal study. LMMs  can analyze such unbalanced
data sets easily (West, 2009). Analyses were run in PASW (V. 17.0) for windows.
3. Results
Table 1 presents the sociodemographic and health behavior
characteristics of the participants at baseline. The groups dif-
fered signiﬁcantly in age (F(3,1721) = 37.9; p < .001) and alcohol use
(F(3,1695) = 39.4; p < .001) with medium effect size (2 = 0.06). The
groups also differed statistically in past year negative life events
(F(3,1721) = 5.1; p < .01) with small effect size (2 = 0.01). Post hoc
comparisons using the Tukey HSD indicated that former smok-
ers were signiﬁcantly older than nicotine-dependent smokers and
both were older than never-smokers and non-dependent smok-
ers (Table 1). Former smokers consumed signiﬁcantly more alcohol
than never-smokers, however, when compared with current smok-
ers they used signiﬁcantly less alcohol (ps < .001). Both current
rs Former smokers
(N = 527)
Effect sizea
t Nicotine-dependent
(N = 349)
41.6 (11.0) 45.6 (11.9) .06***
61.3 66.2 .07*
.14***
16.3 6.5
65.6 57.9
18.1 35.7
6.2 (6.7) 4.6 (4.6) .06***
.09***
29 16.9
31.6 35.9
39.4 47.1
0.8 (1.1) 0.6 (0.9) .01**
79.9 73.8 ns
33.8 18.6 .13***
44.1 38.1 ns
13.5 12.1 ns
31.8 22 .12***
10 13.9 ns
73.9 63.2 .10**
M. Jamal et al. / Drug and Alcohol Dependence 126 (2012) 138– 146 141
Table 2
Mean (SD) severity of the symptoms in participants stratiﬁed by smoking status at baseline.
Severity of symptoms Never-smokers Current smokers Former smokers 2
Non-dependent Nicotine-dependent
Depressive symptoms 29.1 (12.5) 28.0 (12.4) 33.3 (12.6) 27.2 (11.8) 0.03***
Anxiety symptoms 16.1 (10.6) 16.8 (11.0) 20.9 (11.5) 15.3 (9.6) 0.04***
Symptoms of social anxiety 15.1 (8.8) 14.3 (8.6) 16.4 (9.7) 14.4 (8.8) 0.01**
Symptoms of agoraphobia 8.8 (9.0) 9.3 (9.4) 12.6 (10.9) 8.7 (8.8) 0.02***
s
i
n
a
l
T
R
n*** p < .001.
** p < .01.
moking groups were not signiﬁcantly different from each other
n alcohol use (p > .05). Similarly, former smokers reported fewer
egative life events than current smokers (both groups) (p < .05)
nd never-smokers were not different than any of the groups in
ife events (p > .05). A chi-square test indicated that at baseline, the
able 3
egression of smoking status on the severity of the disorders.a
Predictors B
Severity of the symptoms of depression
Age 0.06 
Gender 0.04 
Education −0.61 
Stressful life events 0.87 
Alcohol use −0.05 
Low  vs. moderate physical activity −2.22 
Low vs. high physical activity −3.80 
Never-smokers vs. current smokers (nD)b −1.15 
Never-smokers vs. current smokers (D)b 2.81 
Never-smokers vs. former smokers −2.06 
Severity of the symptoms of anxiety
Age 0.02 
Gender 0.98 
Education −0.59 
Stressful life events 0.57 
Alcohol use −0.02 
Low  vs. moderate physical activity −1.31 
Low  vs. high physical activity −1.80 
Never-smokers vs. current smokers (nD)b 0.64 
Never-smokers vs. current smokers (D)b 3.80 
Never-smokers vs. former smokers −0.71 
Severity of the symptoms of social anxiety
Age −0.01 
Gender 1.35 
Education −0.25 
Stressful life events −0.02 
Alcohol use 0.07 
Low  vs. moderate physical activity −0.33 
Low  vs. high physical activity −1.21 
Never-smokers vs. current smokers (nD)b −0.97 
Never-smokers vs. current smokers (D)b 0.83 
Never-smokers vs. former smokers −0.64 
Severity of the symptoms of agoraphobia
Age 0.02 
Gender 2.04 
Education −0.51 
Stressful life events −0.09 
Alcohol use −0.08 
Low  vs. moderate physical activity −0.91 
Low  vs. high physical activity −1.32 
Never-smokers vs. current smokers (nD)b 0.67 
Never-smokers vs. current smokers (D)b 3.32 
Never-smokers vs. former smokers 0.28 
s = non-signiﬁcant.
a Data has been shown only for the ﬁnal model including all variables.
b nD = non-dependent; D = nicotine-dependent.
* p < .05.
** p < .01.
*** p < .001.groups differed signiﬁcantly in gender (2(3) = 7.9; p < .05), edu-
2 2cation ( (6) = 63.0; p < .001), and physical activity ( (6) = 30.7;
p < .001) with small to medium effect sizes (Table 1). The groups
also differed signiﬁcantly in the prevalence of current diagnoses
of depression (2(3) = 14.6; p < .01), generalized anxiety disorder
SE  ˇ p-Value
0.03 0.060 *
0.64 0.002 ns
0.09 −0.160 ***
0.28 0.07 **
0.06 −0.02 ns
0.82 −0.09 **
0.80 −0.15 ***
0.86 −0.04 ns
0.91 0.09 **
0.81 −0.08 *
0.02 0.03 ns
0.56 0.04 ns
0.08 −0.18 ***
0.24 0.06 *
0.05 −0.01 ns
0.71 −0.06 ns
0.69 −0.08 **
0.74 0.03 ns
0.79 0.14 ***
0.70 −0.03 ns
0.02 −0.01 ns
0.48 0.07 **
0.07 −0.09 ***
0.21 −0.002 ns
0.05 0.04 ns
0.61 −0.02 ns
0.59 −0.07 *
0.64 −0.05 ns
0.68 0.04 ns
0.60 −0.03 ns
0.02 0.03 ns
0.49 0.10 ***
0.07 −0.17 ***
0.22 −0.01 ns
0.05 −0.05 ns
0.63 −0.05 ns
0.61 −0.07 *
0.66 0.03 ns
0.70 0.14 ***
0.62 0.01 ns
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Table 4
Parameter estimates of mixed-effects models examining the relationship between symptom severity of the disorders over time.a
Symptoms of depression Symptoms of anxiety Symptoms of social anxiety Symptoms of agoraphobia
 ˇ 95% CI  ˇ 95% CI  ˇ 95% CI  ˇ 95% CI
Intercept 38.4 24.3, 52.4*** 23.0 11.6, 34.5*** 18.0 5.4, 30.5* 16.5 6.2, 26.8**
Time −3.9 −4.6, −3.1*** −1.9 −2.5, −1.3*** −1.3 −3.0, 0.4 −0.9 −1.5, −0.4**
Former smokers −2.8 −16.0, 10.4 −1.3 −12.4, 9.8 −2.4 −11.9, 7.1 0.8 −8.3, 9.9
Current smokers (nD)b −3.2 −15.8, 9.5 −1.8 −12.2, 8.5 −3.0 −12.7, 6.7 −0.7 −9.9, 8.5
Current smokers (D)b 1.4 −12.0, 14.7 1.4 −9.3, 12.1 −0.7 −10.5, 9.0 3.4 −6.6, 13.4
Never-smokers 0 0 0 0
Interaction with time
Former smokers 0.2 −0.6, 1.1 0.05 −0.7, 0.8 0.07 −1.4, 1.5 −0.3 −0.9, 0.3
Current smokers (nD)b 0.7 −0.3, 1.8 −0.2 −1.1, 0.6 −0.06 −1.2, 1.1 −0.2 −0.9, 0.6
Current smokers (D)b −1.3 −2.4, −0.2* −1.0 −1.8, −0.02* −0.1 −1.9, 1.7 −0.7 −1.3, 0.3
Never-smokers 0 0 0 0
a Models adjusted for covariates.
b nD = non-dependent; D = nicotine-dependent.
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2(3) = 29.9; p < .001), and panic with agoraphobia (2(3) = 25.2;
 < .001). However, no signiﬁcant group differences were found
ps > .05) in the current diagnoses of anxiety, social anxiety, ago-
aphobia, and panic without agoraphobia (Table 1).1
.1. Symptom severity at baseline
A multivariate ANOVA indicated a signiﬁcant difference
mong groups on a linear combination of the dependent
ariables (F(12,5076) = 7.45; p < .001; Pillai’s trace = 0.05; partial
2 = 0.02). All four dependent variables reached statistical signif-
cance: severity of depression (F(3,1693) = 18.4; p < .001; partial
2 = 0.03); anxiety (F(3,1693) = 20.9; p < .001; partial 2 = 0.04);
ocial anxiety (F(3,1693) = 4.2; p < .01; partial 2 = 0.01); agorapho-
ia (F(3,1693) = 13.2; p < .001; partial 2 = 0.02). Tukey HSD revealed
hat on three of the dependent variables (severity of depression,
nxiety and agoraphobia) nicotine-dependent smokers had higher
cores than non-dependent smokers, former smokers and never-
mokers (ps < .001). The latter three groups were not different from
ach other on these variables (ps > .05). For the severity of social
nxiety, results were slightly different. Nicotine-dependent smok-
rs were more socially anxious than former smokers (p < .05) and
on-dependent smokers, but they were not different from never-
mokers (p > .05). The mean scores are presented in Table 2. We
lso repeated similar analyses by combining the two  groups of
urrent smokers and found that current smokers had signiﬁcantly
ore severe depressive and anxiety symptoms than former and
ever-smokers (p < .001), except for social anxiety symptoms.1
Finally, four regression analyses were run. In the regression
nalysis with symptoms of depression as the dependent variable,
he overall variance explained was 8.4% (p < .001). The regres-
ion analysis with symptoms of anxiety as the dependent variable
xplained 8% of the signiﬁcant overall variance (p < .001). Similarly,
or the symptoms of social anxiety and agoraphobia, the overall
ariance explained was 2.3% (p < .05) and 7.4% (p < .001), respec-
ively. For individual contribution of each variable in predicting
ymptom severity, see Table 3.2
1 The demographic characteristics and severity of symptoms of the total sample
f  this study, and that of the combined current smoking groups can be viewed as
upplementary material by accessing the online version of this paper. Please see
ppendix A.
2 The regression analyses with continuous baseline FTND score for all four depen-
ent variables can be viewed as supplementary material by accessing the online
ersion of this paper. Please see Appendix A.We  carried out similar regression analyses by including baseline
FTND score as continuous covariate. A signiﬁcant positive linear
relationship between FTND and severity of symptoms on all four
measures were found, thus conﬁrming our initially reported anal-
yses (Table 3S).2
3.2. Smoking status and the course of depression and anxiety
The severity of depressive and anxiety symptoms in the par-
ticipants over time was evaluated with linear mixed models. The
intercept and linear slope parameters were statistically signiﬁcant
(ps ≤ .001), indicating a signiﬁcant between-participants variation
in the initial status of the dependent variable and linear growth
rate (Table 4). The symptoms of depression, anxiety, social anxiety,
and agoraphobia decreased over time in all four groups. How-
ever, we  found statistically signiﬁcant interaction of time with the
symptoms of depression and anxiety only for nicotine-dependent
smokers (ps < .05) suggesting that depressive and anxiety symp-
toms of dependent smokers improved more slowly as compared
with the other three groups (Table 4). Social anxiety and agora-
phobia symptoms decreased over time, but none of the smoking
groups improved faster or slower than any of the other groups
(ps > .05). Fig. 1 displays change over time in the mean symptoms
of depression and anxiety disorders in the four groups.
4. Discussion
We  examined the severity and course of depressive and anxiety
symptoms by smoking and nicotine dependence status in patients
with current diagnosis of depression/anxiety disorders. Our results
conﬁrmed that the symptoms of depression, anxiety, and agora-
phobia were more severe in nicotine-dependent smokers than in
the other three groups. This pattern remained after controlling
for the effects of covariates. The differences between the groups
in the symptoms of social anxiety, however, were much smaller
and were no longer signiﬁcant after controlling for covariates. We
also found that nicotine-dependent smokers had slower recovery
of depressive and anxiety symptoms than never-smokers, former
smokers, and non-dependent smokers. However, no differences
were observed between the groups for the improvement of the
symptoms of social anxiety and agoraphobia.These results are in line with previous literature on the rates and
severity of depression and anxiety disorders in nicotine-dependent
smokers. After controlling for other substance disorders, nicotine-
dependent smokers (unlike non-dependent smokers) had higher
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fFig. 1. Change in the mean severity of symptoms over time as 
dds of major depression and anxiety disorders (Breslau et al.,
991). Similarly, heavy smoking (Coutino et al., 2009) and nico-
ine dependence (Pedersen and von Soest, 2009) were associated
ith elevated rates of depression and anxiety disorders and higher
everity of depressive symptoms.
Inconsistent with our hypothesis and with previous ﬁndings, we
ound that never-smokers, non-dependent current smokers, and
ormer smokers did not differ signiﬁcantly from each other on base-
ine symptom severity of depression and anxiety. However, when
e combined the current smoking groups, our results were not dif-
erent from previous studies that observed less severe symptoms
f depression and anxiety in former smokers than in current smok-
rs (Lam et al., 2004; Martini et al., 2002). The previous studies did
ot distinguish between dependent and non-dependent smokers.
hus it seems that the association between smoking and severity
f symptoms is mainly carried by nicotine-dependent smokers.
Our ﬁndings should be interpreted by taking into consideration
he following limitations. Firstly, despite the longitudinal design
nd the large sample size, the follow-up period is relatively short.
econdly, the age-group of the participants is heterogeneous.
hirdly, a number of participants had dropped out during the
ollow-up period which might have biased our results because thetion of smoking status. Error bars are 95% conﬁdence intervals.
drop-outs were signiﬁcantly different from those in the study in
a number of parameters including severity of symptoms. Fourthly,
nicotine dependence was assessed only at baseline, and was
not assessed in former smokers. Fifthly, though our ﬁndings are
suggestive of an association of slower symptom recovery with
nicotine dependence, these cannot be taken as inferring causality
due to the naturalistic nature of the study. Fifthly, NESDA may
not be representative of other ethnic groups. Finally, depression
and anxiety disorders are highly comorbid with other mental
health problems, so the exclusion criteria of NESDA may limit the
generalizability of our ﬁndings (Blanco et al., 2008). However, as
compared to NESDA, another large study of early-onset depression,
GENRED, adopted a more stringent exclusion criteria (Levinson
et al., 2003). Despite these limitations, our study focuses on
psychiatric patients whereas most previous longitudinal studies
used population samples. The NESDA’s assessment of depression
and anxiety disorders is based on DSM-IV criteria unlike most
previous studies that assessed symptoms, not diagnoses, and
relied mostly on self-report measures of depressive and anxiety
symptoms. Moreover, anxiety disorders and nicotine dependence
have received relatively little research attention; most studies
have investigated the smoking status-depression association. Thus
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ur ﬁndings of low improvement rate in anxiety and depressive
ymptoms in nicotine-dependent smokers are of particular impor-
ance because nicotine-dependent smokers seem to have reduced
ental health than non-dependent smokers.
The mechanisms underlying the association of smoking or nico-
ine dependence with depression and anxiety disorders are unclear.
ur ﬁndings suggest that quitting smoking may  not always be
ssociated with reductions of depressive and anxiety symptoms,
ecause the former smokers in our study were not signiﬁcantly
ifferent from non-dependent current smokers. However, there is
o assessment of how severe the symptoms of former smokers
ere prior to quitting smoking. Further, there is no information
n how dependent the former smokers were when they quit. It
ay be that it is dependent smoking that exacerbates symptoms
mong this population, but that if these smokers quit they would
otice symptom improvement. Thus, the ﬁndings are inconsistent
ith the assumption that quitting smoking is linked with aggra-
ation in depressive or anxious symptoms (Glassman et al., 2001;
soh et al., 2000). Quitting might be related with high symptoms
n smokers with lower quitting self-efﬁcacy (Haukkala et al., 2000)
r with failed quit attempts (Berlin et al., 2010), but not in those
ho remain abstinent for long period (Korhonen et al., 2011). This
annot be implied, though, from our ﬁndings as there are no data
n quitting self-efﬁcacy or failed quit attempts in NESDA. The for-
er  smokers in our study remained abstinent at an average of
pproximately twelve years (data not shown) which might be the
eason that their symptoms were comparable with never-smokers.
owever, it is still interesting that non-dependent smokers are not
igniﬁcantly different in their symptoms from the non-smoking
roups. Thus our ﬁndings suggest that smoking might be associ-
ted with the onset or the increasing severity of anxiety disorders
nly when smokers are nicotine-dependent.
The worse outcome observed in nicotine-dependent smokers
ight be due to the fact that chronic nicotine use might have an
dverse effect on the brain and the neurotransmission systems. For
xample, nicotine use and anxiety or depression have both been
inked to elevated dopamine (Fride and Weinstock, 1988; Pontieri
t al., 1996), low brain-derived neurotrophic factor (BDNF) levels
Kim et al., 2007; Sen et al., 2008), and low Monoamine Oxidase
MAO) activity (Andersch and Hetta, 2001; Fowler et al., 1996).
uture investigations are needed on the impact of smoking or nico-
ine dependence on the dopamine, BDNF levels and MAO  activity in
elation to anxiety or aversive mood states in order to elucidate the
echanisms, and to help better our understanding of the complex
ssociation.
Regarding the notion of self-medication as motivator for smok-
ng, our ﬁndings suggest that chronic and heavy nicotine use does
ot help to alleviate negative affect and may  be even counterpro-
uctive. This may  be used in educational programs for smokers who
hink that smoking helps them to control their mood states. Our
ndings also point to the importance of considering nicotine depen-
ence symptoms in psychiatric patients in health prevention and
ntervention programs; thus more effective methods for managing
epression and anxiety disorders should be developed. In psychi-
tric patients who smoke, a screening for nicotine dependence
ymptoms in medical settings would be useful to be implemented,
nd nicotine-dependent patients may  be prioritized for smoking
essation programs.
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